SCHEMBL30830643

SCHEMBL30830643

CN(C(=O)OC(C)(C)C)c1ccc(CCCO)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 2/20 0.48
PAX8 Q06710 1/20 0.46
CYP4A11 Q02928 2/20 0.45
NR1H2 P55055 1/20 0.44
CYP4F2 P78329 1/20 0.41
BRD4 O60885 2/20 0.40
CREBBP Q92793 1/20 0.40
LMNA P02545 2/20 0.39
CA2 P00918 1/20 0.37
ALOX5 P09917 1/20 0.36
NR1H4 Q96RI1 1/20 0.35
SSTR4 P31391 1/20 0.35
LTA4H P09960 1/20 0.35
EPHX2 P34913 1/20 0.35
MEN1 O00255 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25960268 0.87 PAX8 (0.45) PPARAPAX8NR1H2BRD4CREBBP
SCHEMBL177445 0.86 THRA (0.47) PAX8LMNAMEN1KMT2A
SCHEMBL7531272 0.84 PAX8 (0.50) PPARAPAX8NR1H2BRD4CREBBP
SCHEMBL25960283 0.84 PAX8 (0.47) PAX8NR1H2BRD4CREBBPLMNA
SCHEMBL6959925 0.84 PAX8 (0.47) PAX8BRD4CREBBPLMNANR1H4
SCHEMBL24542518 0.82 PPARA (0.51) PPARACYP4A11NR1H2CYP4F2CA2
SCHEMBL8018111 0.82 PAX8 (0.55) PAX8NR1H2BRD4CREBBPLMNA
SCHEMBL16197281 0.81 PAX8 (0.50) PAX8NR1H2BRD4CREBBPLMNA
SCHEMBL16202168 0.81 PAX8 (0.45) PAX8BRD4CREBBPLMNACA2
SCHEMBL13674397 0.80 PAX8 (0.49) PAX8NR1H2BRD4CREBBPLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 WO disclosed